# A Phase I Study of XH-S004 in Healthy Volunteers

> **NCT06236841** · PHASE1 · UNKNOWN · sponsor: **S-INFINITY Pharmaceuticals Co., Ltd** · enrollment: 90 (estimated)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** XH-S004 tablet
- **DRUG:** XH-S004 placebo tablet

## Key facts

- **NCT ID:** NCT06236841
- **Lead sponsor:** S-INFINITY Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-26
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06236841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06236841, "A Phase I Study of XH-S004 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06236841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*